刘峰,王炳银

• 1:上海交通大学医学院苏州九龙医院心内科

摘要(Abstract)：

<正>心血管疾病预防和治疗已取得重大进展,但它仍然是全世界死亡的主要原因。我国冠心病的发病率和死亡率仍有增加的趋势。急性冠状动脉综合征(急性冠脉综合征)是冠心病急性死亡的主要形式之一,它的突发性和难以预测性是临床的一大挑战。也引起了广泛的兴趣和极大的重视。现已证明易损斑块是引起心血管急性事件、急性心肌梗死、急性冠脉综合征、脑卒中和猝死的主要原因。而且这种斑块的破损和栓塞既突发又严重,多无先兆和前驱症状,难以预测和诊断,难以预防和治疗,成为心脑血管病的罪魁祸首。因

关键词(KeyWords)：

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 刘峰,王炳银

参考文献(References)：

• [1]Herrick JB.Landmark article(JAMA1912).Clinical features of sudden obstruction of the coronary arteries.By James B.Herrick.JAMA,1983,250:1757-1765.
• [2]Muller JE,Tofler GH,Stone PH.Circadian variation and triggers of onset of acute cardiovascular disease.Circulation,1989,79:733-743.
• [3]Naghavi M,Libby P,Falk E,et al.From vulnerable plaque to vulnerable patient:a call for new definitions and risk assessment strategies:Part I.Circulation,2003,108:1664-1672.
• [4]Naghavi M,Libby P,Falk E,et al.From vulnerable plaque to vulnerable patient.A call for new definition andrisk assessment strategies:partⅡ.Circulation,2003,108:1772-1778.
• [5]Kolodgie FD,Virmani R,Burke AP,et al.Pathologic assessment of the vulnerable human coronary plaque.Heart,2004,90:1385-1391.
• [6]Narula J,Garg P,Achenbach S,et al.Arithmetic of vulnerableplaques for noninvasive imaging.Nat Clin Pract Cardiovasc Med,2008,5Suppl2:S2-S10.
• [7]Virmani R,Burke AP,Farb A,et Al.Pathology of the vulnerable plaque.J Am Coll Cardiol,2006,47:C13-C18.
• [8]Davies MJ.Pathology of arterial thrombosis.Br Med Bull,1994,50:789-802.;
• [9]Burke AP,Kolodgie FD,Farb A,et al.Healed plaque ruptures and sudden coronary death:evidence that subclinical rupture has a role in plaque progression.Circulation,2001,103:934-940.
• [10]杨丽霞,郑甲林,严睿,等.64层螺旋CT联合炎症因子检测急性冠状动脉综合征患者易损斑块的相关研究.中国介入心脏病学杂志,2009,17:316-319.
• [11]Kim DE,Kim JY,Schellingerhout D,et al.Molecular imaging of cathepsin B proteolytic enzyme activity reflects the inflammatory component of atherosclerotic pathology and can quantitatively demonstrate the antiatherosclerotic therapeutic effects of atorvastatin and glucosamine.Mol Imaging,2009,8:291-301.
• [12]Suh WM,Seto AH,Margey RJ,et al.Intravascular Detection of the Vulnerable Plaque.Circ Cardiovasc Imaging,2011,4:169-178.
• [13]Voros S,Rinehart S,Qian Z,et al.Coronary atherosclerosis imaging by coronary CT angiography:current status,correlation with intravascular interrogation and meta-analysis.JACC Cardiovasc Imaging,2011,4:537-548.
• [14]郭远林,陈在嘉,陈纪林.冠状动脉易损斑块检测方法学进展.中国介入心脏病学杂志,2006,14:304-306.
• [15]Deguchi JQ,Aikawa M,Tung CH,et al.Inflammation in atherosclerosis visualizing matrix metalbproteinase action in macrophages in vivo.Circulation,2006,114:55-62.
• [16]Douma K,Megens RT,van Zandvoort,et al.Optical molecular imaging of atherosclerosis using nanoparticles:shedding new light on the darkness.Wiley Interdiscip Rev Nanomed Nanobiotechnol,2011,3:376-388
• [17]Motoyama S,Sarai M,Harigaya H,et al.Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome.J Am Coll Cardiol,2009,54:49-57.
• [18]Kim SH,Hong MK,Park DW,et al.Impact of plaque characteristics analyzed by intravascular ultrasound on long-termclinical outcomes.Am J Cardiol,2009,103:1221-1226.
• [19]Bayturan O,Tuzcu EM,Nicholls SJ,et al.Attenuated plaque at nonculprit lesions in patients enrolled in intravascular ultrasound atherosclerosis progression trials.JACC Cardiovasc Interv,2009,2:672-678.
• [20]Stone GW,Maehara A,Lansky AJ,et al.A prospective natural-history study of coronary atherosclerosis.N Engl J Med,2011,364:226-235.
• [21]Muntendam P,McCall C,Sanz J,et al.The BioImage Study:novel approaches to risk assessment in the primary prevention of atherosclerotic cardiovascular disease-study design and objectives.Am Heart J,2010,160:49-57.
• [22]Puig O,Yuan J,Stepaniants S,et al.A gene expression signature that classifies human atherosclerotic plaque by relative inflammation status.Circ Cardiovasc Genet,2011,4:595-604.
• [23]McCann CJ,Glover BM,Menown IBA,et al.Prognostic value of a multimarker approach for patients presenting to hospital with acute chest pain.Am J Cardiol,2009,103:22-28.
• [24]Lund J,Wittfooth S,Qin QP,et al.Free vs total pregnancy-associated plasma protein A(PAPP-A)as a predictor of1-year outcome in patients presenting with non-ST-elevation acute coronary syndrome.Clin Chem,2010,56:1158-1165.
• [25]Ridker PM,Danielson E,Fonseca FA,et al.Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.N Engl J Med,2008,359:2195-2207.
• [26]Puig O,Yuan J,Stepaniants S,et al.A gene expression signature that classifies human atherosclerotic plaque by relative inflammation status.Circ Cardiovasc Genet,2011,4:595-604.
• [27]Wang LX,LüSZ,Zhang WJ,et al.Comparision of high sensitivity C-reactive protein and matrix metalloproteinase9in patients with unstable angina between with and without significant coronary artery plaques.Chin Med J(Engl),2011,124:1657-1661.
• [28]Granada JF,Kaluza GL,Wilensky RL,et al.Porcine models of coronary atherosclerosis and vulnerable plaque for imaging and interventional research.EuroIntervention,2009,5:140-148.
• [29]Thim T.Human-like atherosclerosis in minipigs:a new model for detection and treatment of vulnerable plaques.Dan Med Bull,2010,57:B4161.